Many people with Type 1 diabetes will get "artificial pancreas" technology for free this year thanks to deals secured by ...

During descent (ambient pressure increase), cartridges under-delivered 0.51 units of insulin. This may lead to blood glucose being higher than usual but does not pose the same concern as the ...

Air bubble formation from pressure changes causes the pump to deliver about 0.6 extra units on ascent and about 0.5 less on ...

According to Research by SNS Insider, The Insulin Pump Market Growth is Driven by Rising Prevalence of Diabetes and ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

Type 1 diabetes is a chronic autoimmune disease in which the immune system attacks and destroys the cells in the pancreas that produce insulin. To make up for the deficiency, patients have to be ...

Ypsomed reports positive outcomes from a randomized trial of its closed-loop insulin delivery technology during type 1 ...

The monitors - which Pharmac is now funding for all type 1 diabetics - mean patients are less likely to suffer early deaths, ...

Lead of the Co-Pilot Trial, Professor Ben Wheeler, of Otago’s Department of Women's and Children's Health, says the study and its findings are “extremely important” for the millions of people ...

The NHS is a global leader in rolling out the cutting-edge technology to patients, with industry choosing the UK as a first-choice destination to launch the latest products in this space.

According to autopsy findings, the diabetic inmate's insulin pump was likely beeping nonstop for nearly 24 hours, alerting ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that ...